BIO-Europe: The countdown has begun

Preparations for Europe’s leading conference for the biotech and pharmaceutical industry are entering the crucial stage: Next week, from November 11-13, BIO-Europe will be opening its doors for the 25th time – this time at the Hamburg Messe. "After 2007 and 2012, BIO-Europe is returning to Hamburg for a third time," says LSN Managing Director Hinrich Habeck. "As cluster management, we see the congress as a great opportunity to showcase the diverse competencies of the North on the international stage." To this end, Life Science Nord has joined forces with the companies Evotec, Nordmark, Indivumed, and Eppendorf and the federal states of Hamburg and Schleswig-Holstein to form the 'Regional Host Committee' and optimally present the industry and region to the approximately 4,500 guests. From a joint stand with another 16 companies from the cluster and an evening event in the impressive Kuppel on Monday, November 11 through the conference program, the host companies are well prepared for BIO-Europe. Want to find out more about the regional hosts and BIO-Europe in Hamburg? During the countdown week, we'll be posting several short video profiles of the partners in the Regional Host Committee on our Twitter channel. The latest issue of the LSN Magazine is also dedicated to BIO-Europe, featuring the special topic 'Smart Drug Discovery'.

More Information

More News

GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)
GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)

Pacira BioSciences Acquires GQ Bio

HTGF portfolio company GQ Bio, pioneering a high-capacity adenovirus gene therapy vector platform, was acquired by Pacira BioSciences, Inc. Pacira, the industry leader in its ...

Read more …
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)

CrystalsFirst Scales Operations...

CrystalsFirst, a leading provider of advanced structural biology solutions and AI-driven drug discovery, is pleased to announce a multi-million-euro expansion of its laboratory infrastructure and ...

Read more …
medac has received FDA approval for treosulfan (Copyright Adobe Stock - Nicolas Hermbach)

Strategic cornerstone for medac: FDA approves treosulfan for alloHSCT

medac has received FDA approval for treosulfan as a new drug application with orphan drug designation prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...

Read more …